Journals / E Journal of Cardiovascular Medicine / 2022 / Cilt: 10 - Sayı: 2

Comparison of Ischemia-modified Albumin and Exercise Stress Test in Stable Angina Pectoris

Pages
64–71
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They were divided into groups with and without coronary artery disease (CAD) according to the results of coronary angiography and with and without ischemia according to the stress electrocardiogram (ECG) results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to compare ischemia modified albumin (IMA) and exercise stress test to determine myocardial ischemia in stable angina pectoris and investigate the diagnostic value of IMA in non-exercised patients.
📊
Key Findings & Data:Results: The IMA was found to be 1.06±0.23 in patients with CAD and 1.12±0.18 in patients without CAD (p=0.08).
💡
Conclusion & Impact:They were divided into groups with and without coronary artery disease (CAD) according to the results of coronary angiography and with and without ischemia according to the stress electrocardiogram (ECG) results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to compare ischemia modified albumin (IMA) and exercise stress test to determine myocardial ischemia in stable angina pectoris and investigate the diagnostic value of IMA in non-exercised patients. Materials and Methods: One hundred and eight patients who applied to the cardiology outpatient clinic with chest pain and were diagnosed with ischemia on myocardial perfusion scintigraphy were included in the study. They were divided into groups with and without coronary artery disease (CAD) according to the results of coronary angiography and with and without ischemia according to the stress electrocardiogram (ECG) results. In addition, IMA levels of the patients were measured, and an exercise stress test was performed. Results: The IMA was found to be 1.06±0.23 in patients with CAD and 1.12±0.18 in patients without CAD (p=0.08). Statistically, between the groups, IMA determined no significant evidence for ischemia in stable angina pectoris. Conclusion: No significant difference was found between exercise ECG and IMA in the study of patient groups to determine myocardial ischemia in patients with stable angina pectoris. That is why it has been concluded that the measurement of IMA does not help determine myocardial ischemia in immobile patients and that it cannot be used in place of a stress ECG test.

🔖

Cite This Article

ÖZMEN, M., KARAKELLEOĞLU, Ş., ARDAHANLI, İ. (2022). Comparison of Ischemia-modified Albumin and Exercise Stress Test in Stable Angina Pectoris. E Journal of Cardiovascular Medicine, Cilt: 10 - Sayı: 2, 64–71. https://ajindex.com/articles/498200

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Antman EM, Braunwald E. Managing stable ischemic heart disease. N Engl J Med 2020;382:1468-70.
  2. Katta N, Loethen T, Lavie CJ, Alpert MA. Obesity and coronary heart disease: epidemiology, pathology, and coronary artery imaging. Curr Probl Cardiol 2021;46:100655. Banning AP, Crea F, Lüscher TF. The year in cardiology: acute coronary syndromes. Eur Heart J 2020;41:821-32.
  3. Coverdale JPC, Katundu KGH, Sobczak AIS, Arya S, Blindauer CA, Stewart AJ. Ischemia-modified albumin: crosstalk between fatty acid and cobalt binding. Prostaglandins Leukot Essent Fatty Acids 2018;135:147- 57. Savci U, Senel E, Oztekin A, Sungur M, Erel O, Neselioglu S. Ischemia modified albumin as a possible marker of oxidative stress in patients with telogen effluvium. An Bras Dermatol 2020;95:447-51.
  4. Lim ZX, Duong MN, Boyatzis AE, et al. Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress. Free Radic Res 2020;54:91- 103. Mishra B, Pandey S, Niraula SR, et al. Utility of ischemia modified albumin as an early marker for diagnosis of acute coronary syndrome. J Nepal Health Res Counc 2018;16:16-21.
  5. Hazini A, Cemek M, Işıldak İ, et al. Investigation of ischemia modified albumin, oxidant and antioxidant markers in acute myocardial infarction. Postepy Kardiol Interwencyjnej 2015;11:298-303.
  6. Mehta MD, Marwah SA, Ghosh S, Shah HN, Trivedi AP, Haridas N. A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome. J Family Med Prim Care 2015;4:570-75.
  7. Kim MC, Ahn Y. The value of exercise stress test in patients with stable ischemic heart disease. J Korean Med Sci 2020;35:e21. Mou H, Shao J, Zhang J, Yang J, Yu S, Wang H. Ischemia-modified albumin to evaluate short-term prognostic of patients with acute coronary syndrome. J Coll Physicians Surg Pak 2021;30:841-45.
  8. Demirtas AO, Karabag T, Demirtas D. Ischemic modified albumin predicts critical coronary artery disease in unstable angina pectoris and non-stelevation myocardial infarction. J Clin Med Res 2018;10:570-75.
  9. Wudkowska A, Goch J, Goch A. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris. Kardiol Pol 2010;68:431-37.
  10. Worster A, Devereaux PJ, Heels-Ansdell D, et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005;172:1685-90.
  11. Mutrie D, Pollack CV, Lai C, et al. Does